Ontario Teachers Pension Plan Board Has $1.84 Million Stake in Encompass Health Co. (NYSE:EHC)

Ontario Teachers Pension Plan Board lowered its stake in shares of Encompass Health Co. (NYSE:EHC) by 65.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,077 shares of the company’s stock after selling 36,346 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Encompass Health were worth $1,844,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. boosted its holdings in Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after buying an additional 26,270 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in Encompass Health by 85.6% during the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after buying an additional 6,627 shares during the last quarter. SG Americas Securities LLC bought a new position in Encompass Health during the second quarter worth about $2,204,000. Los Angeles Capital Management LLC boosted its holdings in Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after buying an additional 42,338 shares during the last quarter. Finally, Kennedy Capital Management LLC boosted its holdings in Encompass Health by 19.6% during the first quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company’s stock worth $8,235,000 after buying an additional 16,318 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 0.2 %

NYSE:EHC opened at $99.08 on Wednesday. The firm has a market capitalization of $9.98 billion, a price-to-earnings ratio of 23.93, a price-to-earnings-growth ratio of 1.31 and a beta of 0.88. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55. The stock’s 50 day moving average price is $96.69 and its two-hundred day moving average price is $90.58. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 EPS. Equities research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health declared that its Board of Directors has approved a stock buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to repurchase up to 5.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its stock is undervalued.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. Encompass Health’s dividend payout ratio is currently 16.43%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Stephens reaffirmed an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. KeyCorp raised their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group raised their price target on Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Finally, Royal Bank of Canada raised their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.